BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 20104022)

  • 1. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
    Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
    Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system.
    Ju JS; Weihl CC
    Autophagy; 2010 Feb; 6(2):283-5. PubMed ID: 20083896
    [No Abstract]   [Full Text] [Related]  

  • 5. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
    Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
    PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
    Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
    Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
    Weihl CC; Pestronk A; Kimonis VE
    Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
    Weihl CC; Miller SE; Hanson PI; Pestronk A
    Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
    J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
    Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
    Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
    Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
    PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
    Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
    Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valosin-containing protein gene mutations: clinical and neuropathologic features.
    Guyant-Maréchal L; Laquerrière A; Duyckaerts C; Dumanchin C; Bou J; Dugny F; Le Ber I; Frébourg T; Hannequin D; Campion D
    Neurology; 2006 Aug; 67(4):644-51. PubMed ID: 16790606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological consequences of VCP mutations on human striated muscle.
    Hübbers CU; Clemen CS; Kesper K; Böddrich A; Hofmann A; Kämäräinen O; Tolksdorf K; Stumpf M; Reichelt J; Roth U; Krause S; Watts G; Kimonis V; Wattjes MP; Reimann J; Thal DR; Biermann K; Evert BO; Lochmüller H; Wanker EE; Schoser BG; Noegel AA; Schröder R
    Brain; 2007 Feb; 130(Pt 2):381-93. PubMed ID: 16984901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
    Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
    Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.